Design Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
CARLSBAD, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for degenerative genetic disorders, today reported that João Siffert, M.D., president and chief executive officer, will participate in a fireside chat during the Goldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 1:20 p.m. ET.
The live webcast will be available in the investor section of the company's website at www.designtx.com. The webcast will be archived for 60 days following the presentation.
About Design Therapeutics
ITEXPO #TECHSUPERSHOW Exhibit Hall Open
Keynote Presentation - Security Through a CISOâ€™s Lens
Keynote Presentation - Eric Burger, Former FCC CTO